To verify this phenomenon, dCAS9-DNMT3a- and sgRNA-targeting RAGE promoter regions were transfected into the cells to counteract the effect of CML/CEL. This evidence concerns the gene DNMT3A and chronic myelogenous leukemia, BCR-ABL1 positive.